These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1697709)

  • 21. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
    Sauvageot J; Epstein JI
    Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
    van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex.
    Sinha AA; Wilson MJ; Gleason DF
    Cancer; 1987 Sep; 60(6):1288-93. PubMed ID: 2441840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
    Daver A; Soret JY; Coblentz Y; Allain YM; Cellier P; Chauveau P
    Am J Clin Oncol; 1988; 11 Suppl 2():S53-60. PubMed ID: 2468273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
    Oosterom R; Bogdanowicz J; Schröder FH
    Eur Urol; 1989; 16(4):253-7. PubMed ID: 2475344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
    Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate specific antigen. Experimental and clinical observations.
    Huber PR; Schnell Y; Hering F; Rutishauser G
    Scand J Urol Nephrol Suppl; 1987; 104():33-9. PubMed ID: 2449722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
    van Dieijen-Visser MP; Hendriks MW; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 Sep; 177(1):77-80. PubMed ID: 2460272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of PSA and PAP in patients with or without prostatic cancer.
    Caty A; Gosselin P; Cazin JL; Dehaut JM; Adenis L
    Am J Clin Oncol; 1988; 11 Suppl 2():S63-4. PubMed ID: 2468275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
    Mathieu MC; Caillaud JM
    Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.
    McEntee M; Isaacs W; Smith C
    Prostate; 1987; 11(2):163-70. PubMed ID: 2444955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
    Rainwater LM; Morgan WR; Klee GG; Zincke H
    Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen in management of prostatic carcinoma.
    Brawer MK; Lange PH
    Urology; 1989 May; 33(5 Suppl):11-6. PubMed ID: 2469244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with prostate-specific antigen in prostatic carcinoma.
    Romics I; Bach D
    Int Urol Nephrol; 1991; 23(5):465-72. PubMed ID: 1718923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical study of prostatic acid phosphatase and prostatic specific antigen in prostatic carcinoma--a comparison of monoclonal antibody to polyclonal antibody].
    Moriyama N; Taniguchi J; Hara M; Fukutani K; Matsushima H; Murakami T; Isurugi K; Kawabe K; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1992-7. PubMed ID: 2453695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical detection of prostate carcinoma].
    Ma WX; Li W
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.